These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 11397623)

  • 1. Limits of deep salvage antiretroviral therapy with nelfinavir plus either efavirenz or nevirapine, in highly pre-treated patients with HIV disease.
    Manfredi R; Chiodo F
    Int J Antimicrob Agents; 2001 Jun; 17(6):511-6. PubMed ID: 11397623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of efavirenz as a part of late rescue antiretroviral treatment.
    Manfredi R; Rizzo E; Calza L; Chiodo F
    HIV Clin Trials; 2001; 2(5):413-20. PubMed ID: 11673816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective comparison of the two main indications of efavirenz in 2001 highly active antiretroviral therapy (HAART) regimens: first-line versus salvage use.
    Manfredi R; Calza L; Chiodo F
    J Antimicrob Chemother; 2002 May; 49(5):723-9. PubMed ID: 12003964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized trial comparing initial HAART regimens of nelfinavir/nevirapine and ritonavir/saquinavir in combination with two nucleoside reverse transcriptase inhibitors.
    Kirk O; Lundgren JD; Pedersen C; Mathiesen LR; Nielsen H; Katzenstein TL; Obel N; Gerstoft J
    Antivir Ther; 2003 Dec; 8(6):595-602. PubMed ID: 14760893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First-line nevirapine in combination with nucleoside analogues compared with nevirapine added to a salvage HAART.
    Manfredi R; Chiodo F
    Infection; 2000; 28(3):167-70. PubMed ID: 10879643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nelfinavir, efavirenz, or both after the failure of nucleoside treatment of HIV infection.
    Albrecht MA; Bosch RJ; Hammer SM; Liou SH; Kessler H; Para MF; Eron J; Valdez H; Dehlinger M; Katzenstein DA;
    N Engl J Med; 2001 Aug; 345(6):398-407. PubMed ID: 11496850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiretroviral treatment. HIV infection in adults: better-defined first-line treatment.
    Prescrire Int; 2004 Aug; 13(72):144-50. PubMed ID: 15532140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Virological suppression at 6 months is related to choice of initial regimen in antiretroviral-naive patients: a cohort study.
    Matthews GV; Sabin CA; Mandalia S; Lampe F; Phillips AN; Nelson MR; Bower M; Johnson MA; Gazzard BG
    AIDS; 2002 Jan; 16(1):53-61. PubMed ID: 11741163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The nucleoside backbone affects durability of efavirenz- or nevirapine-based highly active antiretroviral therapy in antiretroviral-naive individuals.
    Annan NT; Nelson M; Mandalia S; Bower M; Gazzard BG; Stebbing J
    J Acquir Immune Defic Syndr; 2009 Jun; 51(2):140-6. PubMed ID: 19352201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects on immunological and virological outcome of patients using one protease inhibitor or one non-nucleoside reverse transcriptase inhibitor in a triple antiretroviral therapy: normal clinical practice versus clinical trial findings.
    Fethi T; Asma J; Amine SM; Amel EB; Taoufik BC; Mohamed C; Amel LO; Mounira G
    Curr HIV Res; 2005 Jul; 3(3):271-6. PubMed ID: 16022658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efavirenz versus nevirapine in current clinical practice: a prospective, open-label observational study.
    Manfredi R; Calza L; Chiodo F
    J Acquir Immune Defic Syndr; 2004 Apr; 35(5):492-502. PubMed ID: 15021314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative biological and clinical outcomes after a switch from a virologically unsuccessful first protease inhibitor-containing antiretroviral combination to a 3-drug regimen containing efavirenz, nevirapine, or abacavir.
    Abgrall S; Yeni PG; Bouchaud O; Costagliola D;
    Clin Infect Dis; 2007 Jan; 44(1):120-7. PubMed ID: 17143827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nevirapine- versus efavirenz-based highly active antiretroviral therapy regimens in antiretroviral-naïve patients with advanced HIV infection.
    Manosuthi W; Sungkanuparph S; Vibhagool A; Rattanasiri S; Thakkinstian A
    HIV Med; 2004 Mar; 5(2):105-9. PubMed ID: 15012650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Depo-medroxyprogesterone in women on antiretroviral therapy: effective contraception and lack of clinically significant interactions.
    Cohn SE; Park JG; Watts DH; Stek A; Hitti J; Clax PA; Yu S; Lertora JJ;
    Clin Pharmacol Ther; 2007 Feb; 81(2):222-7. PubMed ID: 17192768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of a nelfinavir- and nevirapine-containing salvage regimen.
    Sullivan AK; Nelson MR; Shaw A; Moyle GJ; Mandalia S; Gazzard BG; Asboe D
    HIV Clin Trials; 2000; 1(1):7-12. PubMed ID: 11590484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nevirapine or efavirenz combined with two nucleoside reverse transcriptase inhibitors compared to HAART: a meta-analysis of randomized clinical trials.
    Torre D; Tambini R; Speranza F
    HIV Clin Trials; 2001; 2(2):113-21. PubMed ID: 11590519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salvage therapy with abacavir plus efavirenz or nevirapine in HIV-1-infected persons with previous nucleoside analogue and protease inhibitor use.
    Moyle GJ; Wilkins E; Leen C; Cheesbrough A; Reynolds B; Gazzard BG
    AIDS; 2000 Jul; 14(10):1453-4. PubMed ID: 10930162
    [No Abstract]   [Full Text] [Related]  

  • 18. A randomized trial of 2 different 4-drug antiretroviral regimens versus a 3-drug regimen, in advanced human immunodeficiency virus disease.
    Fischl MA; Ribaudo HJ; Collier AC; Erice A; Giuliano M; Dehlinger M; Eron JJ; Saag MS; Hammer SM; Vella S; Morse GD; Feinberg JE; Demeter LM; Eshleman SH;
    J Infect Dis; 2003 Sep; 188(5):625-34. PubMed ID: 12934177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salvage therapy with abacavir plus a non-nucleoside reverse transcriptase inhibitor and a protease inhibitor in heavily pre-treated HIV-1 infected patients. Swiss HIV Cohort Study.
    Khanna N; Klimkait T; Schiffer V; Irigoyen J; Telenti A; Hirschel B; Battegay M
    AIDS; 2000 May; 14(7):791-9. PubMed ID: 10839586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of nevirapine in combination with nelfinavir in heavily pretreated HIV-1-infected patients: a prospective, open-label, controlled, randomized study.
    Jensen-Fangel S; Thomsen HF; Larsen L; Black FT; Obel N
    J Acquir Immune Defic Syndr; 2001 Jun; 27(2):124-9. PubMed ID: 11404533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.